Hologic has joined forces with leading point-of-care diagnostics developers to integrate its proprietary software-defined imaging platform into portable, bedside devices. With the CMS ACCESS Model set to launch in July 2026 and steer Medicare reimbursements toward outcome-based care, Hologic’s solution—combining real-time AI analysis with sub-millimeter resolution—aims to capture a share of the projected $70.92 billion point-of-care diagnostics market by 2032. The company reports that its next-generation handheld scanner, currently in late-stage clinical validation, achieves image quality on par with conventional 1.5 T MRI at a fraction of the cost and has demonstrated a 25% reduction in scan time during multicenter studies.

This month Hologic rolled out Ultimate Defense, a nationwide initiative urging women aged 21 to 65 to undergo routine Pap and HPV co-testing every five years. The campaign responds to CDC data indicating that roughly 20% of eligible U.S. women are underscreened, contributing to an estimated 13,000 annual cervical cancer diagnoses. Hologic plans to fund community outreach programs in 10 states with the highest underscreening rates, allocate $4 million to digital education tools, and partner with 500 clinics by year-end to offer no-cost testing during National Cervical Health Awareness Month.